IKAROS-silenced enhancers regulate oncogenic pathways in IKAROS-null T-ALL (Fig. S15), which suggests that silencing enhancers that regulate expression of oncogenes is one of the mechanisms through which IKAROS exerts a tumor suppressor function in T-ALL. Here, IKZF1 is linked to acute lymphoblastic leukemia.